BGICC25 Updates: Dr. Omalkhair Abualkhair on Hereditary Cancer Awareness
The 17th BGICC (Breast Gynecological and Immunooncology International Cancer Conference) was held on 23rd-24th January 2025 at the Hilton Heliopolis Hotel in Cairo, Egypt. This conference, recognized as the largest and most prestigious cancer event in Africa and the Middle East, served as a major platform for discussing the latest updates and trends in breast and gynecological cancers.
Under the slogan “Illumination and Creation,” it also highlighted advancements in genetics and immuno-oncology, covering all oncology aspects from diagnosis to future innovations. The event featured a range of scientific and educational symposia, workshops, debates, and recommendation sessions, with collaborations from world-renowned scientists and esteemed societies.
Dr. Omalkhair Abualkhair, Senior consultant medical oncology / chairman of oncology department at Dr Sulaiman Al Habib Medical Group, and Associate Professor at Al-Faisal University, joins OncoDaily to discuss the importance of hereditary cancer awareness. She highlights the role of early detection and prevention in improving patient outcomes, particularly in women’s malignancies. Dr. Abualkhair emphasizes the need to break the stigma around hereditary cancer, educate both the public and healthcare providers, and promote proactive healthcare measures.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023